Literature DB >> 19572086

Coronary heart disease risk, aspirin use, and apolipoprotein(a) 4399Met allele in the Atherosclerosis Risk in Communities (ARIC) study.

Dov Shiffman, Daniel I Chasman, Christie M Ballantyne, Vijay Nambi, James J Devlin, Eric Boerwinkle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19572086      PMCID： PMC4351745          DOI： 10.1160/TH09-01-0037

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  5 in total

1.  Prediction of coronary heart disease risk using a genetic risk score: the Atherosclerosis Risk in Communities Study.

Authors:  Alanna C Morrison; Lance A Bare; Lloyd E Chambless; Stephen G Ellis; Mary Malloy; John P Kane; James S Pankow; James J Devlin; James T Willerson; Eric Boerwinkle
Journal:  Am J Epidemiol       Date:  2007-04-18       Impact factor: 4.897

2.  A polymorphism in the protease-like domain of apolipoprotein(a) is associated with severe coronary artery disease.

Authors:  May M Luke; John P Kane; Dongming M Liu; Charles M Rowland; Dov Shiffman; June Cassano; Joseph J Catanese; Clive R Pullinger; Diane U Leong; Andre R Arellano; Carmen H Tong; Irina Movsesyan; Josephina Naya-Vigne; Curtis Noordhof; Nicole T Feric; Mary J Malloy; Eric J Topol; Marlys L Koschinsky; James J Devlin; Stephen G Ellis
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-06-14       Impact factor: 8.311

3.  Association of gene variants with incident myocardial infarction in the Cardiovascular Health Study.

Authors:  Dov Shiffman; Ellen S O'Meara; Lance A Bare; Charles M Rowland; Judy Z Louie; Andre R Arellano; Thomas Lumley; Kenneth Rice; Olga Iakoubova; May M Luke; Bradford A Young; Mary J Malloy; John P Kane; Stephen G Ellis; Russell P Tracy; James J Devlin; Bruce M Psaty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-11-01       Impact factor: 8.311

4.  Polymorphism in the apolipoprotein(a) gene, plasma lipoprotein(a), cardiovascular disease, and low-dose aspirin therapy.

Authors:  Daniel I Chasman; Dov Shiffman; Robert Y L Zee; Judy Z Louie; May M Luke; Charles M Rowland; Joseph J Catanese; Julie E Buring; James J Devlin; Paul M Ridker
Journal:  Atherosclerosis       Date:  2008-07-26       Impact factor: 5.162

5.  Analysis of 17,576 potentially functional SNPs in three case-control studies of myocardial infarction.

Authors:  Dov Shiffman; John P Kane; Judy Z Louie; Andre R Arellano; David A Ross; Joseph J Catanese; Mary J Malloy; Stephen G Ellis; James J Devlin
Journal:  PLoS One       Date:  2008-08-06       Impact factor: 3.240
  5 in total
  2 in total

1.  Lipoprotein(a) in atherosclerosis: from pathophysiology to clinical relevance and treatment options.

Authors:  Andreja Rehberger Likozar; Mark Zavrtanik; Miran Šebeštjen
Journal:  Ann Med       Date:  2020-06-08       Impact factor: 4.709

Review 2.  Emerging genomic applications in coronary artery disease.

Authors:  Samir B Damani; Eric J Topol
Journal:  JACC Cardiovasc Interv       Date:  2011-05       Impact factor: 11.195
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.